Evaluation of in-house ELISA and 11 commercial ELISA kits in the serological diagnosis of COVID-19

W. Rastawicki, Klaudia Płaza, Adam Pietrusiński
{"title":"Evaluation of in-house ELISA and 11 commercial ELISA kits in the serological diagnosis of COVID-19","authors":"W. Rastawicki, Klaudia Płaza, Adam Pietrusiński","doi":"10.32394/mdm.73.04","DOIUrl":null,"url":null,"abstract":"Introduction: ELISA-Immunoassays can complement the molecular diagnostic methods, and can be one of the important tools of sero-surveillance and vaccine evaluation. The aim of the presented study was to develop in-house ELISA and evaluate 11 commercial ELISA tests for detection of anti-SARS-CoV-2 antibodies in serum samples collected from COVID patients.\nMethods: In total, 237 serum samples obtained from 165 people with COVID-19 with RT-PCR confirmed SARS-CoV-2 virus infection were used for the study. The specificity of the developed in-house ELISA kit was tested using 170 serum samples obtained from patients with various bacterial and viral infections. The study used an in-house ELISA and 11 commercial ELISA kits developed by various manufacturers.\nResults: The presented study showed high sensitivity (81.0%) and specificity (97.2%) of the developed in-house kit in relation to the RT-PCR method. The sensitivity of the inhouse test significantly increased (98.1%) when only convalescents - persons at least 3 weeks after COVID-19 were examined. Commercial ELISA kits most frequently detected IgG antibodies (from 44.9% to 89.4%), especially in samples obtained later in the disease, and the least frequent detection of IgM antibodies (from 4.2% to 42.4%).\nConclusions: All the presented ELISA kits may be used in serodiagnosis of COVID-19 however the detection of antibodies in individual tests differed quite significantly and was dependent on the period of the disease, on the class of immunoglobulins and the type of antigen used. The sensitivity of serological tests in the IgG class is clearly higher when examining samples obtained at least 2-3 weeks from the onset of clinical symptoms.\nSearching for IgA antibodies may be useful mainly in the early phase of the disease while IgM antibodies does not provide significant additional information. In the case of asymptomatic or mild infection, the level of antibodies is low which may be the cause problems with the correct interpretation of epidemiological surveys","PeriodicalId":18566,"journal":{"name":"Medycyna doświadczalna i mikrobiologia","volume":"62 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medycyna doświadczalna i mikrobiologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32394/mdm.73.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: ELISA-Immunoassays can complement the molecular diagnostic methods, and can be one of the important tools of sero-surveillance and vaccine evaluation. The aim of the presented study was to develop in-house ELISA and evaluate 11 commercial ELISA tests for detection of anti-SARS-CoV-2 antibodies in serum samples collected from COVID patients. Methods: In total, 237 serum samples obtained from 165 people with COVID-19 with RT-PCR confirmed SARS-CoV-2 virus infection were used for the study. The specificity of the developed in-house ELISA kit was tested using 170 serum samples obtained from patients with various bacterial and viral infections. The study used an in-house ELISA and 11 commercial ELISA kits developed by various manufacturers. Results: The presented study showed high sensitivity (81.0%) and specificity (97.2%) of the developed in-house kit in relation to the RT-PCR method. The sensitivity of the inhouse test significantly increased (98.1%) when only convalescents - persons at least 3 weeks after COVID-19 were examined. Commercial ELISA kits most frequently detected IgG antibodies (from 44.9% to 89.4%), especially in samples obtained later in the disease, and the least frequent detection of IgM antibodies (from 4.2% to 42.4%). Conclusions: All the presented ELISA kits may be used in serodiagnosis of COVID-19 however the detection of antibodies in individual tests differed quite significantly and was dependent on the period of the disease, on the class of immunoglobulins and the type of antigen used. The sensitivity of serological tests in the IgG class is clearly higher when examining samples obtained at least 2-3 weeks from the onset of clinical symptoms. Searching for IgA antibodies may be useful mainly in the early phase of the disease while IgM antibodies does not provide significant additional information. In the case of asymptomatic or mild infection, the level of antibodies is low which may be the cause problems with the correct interpretation of epidemiological surveys
国产ELISA和11种市售ELISA试剂盒在COVID-19血清学诊断中的评价
elisa免疫检测是分子诊断方法的补充,是血清监测和疫苗评价的重要工具之一。本研究的目的是开发内部ELISA并评估11种商用ELISA检测试剂盒,用于检测从COVID患者收集的血清样本中的抗sars - cov -2抗体。方法:从165例经RT-PCR确诊为SARS-CoV-2病毒感染的COVID-19患者中采集237份血清样本进行研究。使用从各种细菌和病毒感染患者获得的170份血清样本,对开发的内部ELISA试剂盒的特异性进行了测试。该研究使用了一种内部ELISA和11种由不同制造商开发的商用ELISA试剂盒。结果:本研究显示,与RT-PCR方法相比,开发的内部试剂盒具有较高的灵敏度(81.0%)和特异性(97.2%)。仅在COVID-19后至少3周的康复者进行检查时,室内测试的敏感性显著提高(98.1%)。商业ELISA试剂盒最常检测到IgG抗体(从44.9%到89.4%),特别是在疾病后期获得的样本中,IgM抗体的检测频率最低(从4.2%到42.4%)。结论:所有ELISA试剂盒均可用于COVID-19的血清诊断,但单项检测中抗体的检测差异较大,且与病程、免疫球蛋白种类和抗原类型有关。当检测从临床症状开始至少2-3周获得的样本时,IgG类血清学检测的敏感性明显更高。寻找IgA抗体可能主要在疾病的早期阶段有用,而IgM抗体不能提供重要的附加信息。在无症状或轻度感染的情况下,抗体水平较低,这可能导致流行病学调查的正确解释出现问题
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信